PT - JOURNAL ARTICLE AU - Landry, Taylor AU - Laing, Brenton Thomas AU - Li, Peixin AU - Bunner, Wyatt AU - Rao, Zhijian AU - Prete, Amber AU - Sylvestri, Julia AU - Huang, Hu TI - Central α-Klotho Suppresses NPY/AgRP Neuron Activity and Regulates Metabolism in Mice AID - 10.2337/db19-0941 DP - 2020 Jul 01 TA - Diabetes PG - 1368--1381 VI - 69 IP - 7 4099 - http://diabetes.diabetesjournals.org/content/69/7/1368.short 4100 - http://diabetes.diabetesjournals.org/content/69/7/1368.full SO - Diabetes2020 Jul 01; 69 AB - α-Klotho is a circulating factor with well-documented antiaging properties. However, the central role of α-klotho in metabolism remains largely unexplored. The current study investigated the potential role of central α-klotho to modulate neuropeptide Y/agouti-related peptide (NPY/AgRP)-expressing neurons, energy balance, and glucose homeostasis. Intracerebroventricular administration of α-klotho suppressed food intake, improved glucose profiles, and reduced body weight in mouse models of type 1 and 2 diabetes. Furthermore, central α-klotho inhibition via an anti–α-klotho antibody impaired glucose tolerance. Ex vivo patch clamp electrophysiology and immunohistochemical analysis revealed that α-klotho suppresses NPY/AgRP neuron activity, at least in part, by enhancing miniature inhibitory postsynaptic currents. Experiments in hypothalamic GT1-7 cells observed that α-klotho induces phosphorylation of AKTser473, ERKthr202/tyr204, and FOXO1ser256 as well as blunts AgRP gene transcription. Mechanistically, fibroblast growth factor receptor 1 (FGFR1) inhibition abolished the downstream signaling of α-klotho, negated its ability to modulate NPY/AgRP neurons, and blunted its therapeutic effects. Phosphatidylinositol 3 kinase (PI3K) inhibition also abolished α-klotho’s ability to suppress food intake and improve glucose clearance. These results indicate a prominent role of hypothalamic α-klotho/FGFR1/PI3K signaling in the modulation of NPY/AgRP neuron activity and maintenance of energy homeostasis, thus providing new insight into the pathophysiology of metabolic disease.